Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH Claritas Pharmaceuticals, Inc.April 14, 2021 GMT SAN FRANCISCO and TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into a binding Letter of Intent (the “LOI”) with Salzman Group, Inc. (a Delaware corporation), Salzman Group, Ltd. (an Israeli corporation), and Salzm...